We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

LumiraDx

LumiraDx develops, manufactures and commercializes industry-leading point of care (POC) diagnostic platforms that use... read more Featured Products: More products

Download Mobile App





2021 AACC Annual Scientific Meeting & Clinical Lab Expo to Offer Free Onsite COVID-19 Testing

By LabMedica International staff writers
Posted on 09 Sep 2021
Print article
Illustration
Illustration
In its ongoing efforts to make the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo safe and healthy, the American Association for Clinical Chemistry (AACC; Washington, DC, USA), in association with LumiraDx (London, UK), will offer free onsite COVID-19 testing to all in-person attendees.

This year's AACC Annual Scientific Meeting, held in partnership with the Canadian Society of Clinical Chemists, will be a live event and has moved from Anaheim to Atlanta due to stringent COVID-19 lockdown requirements in California, with the meeting dates also being moved by one week to September 26-30. The latest move to offer onsite COVID-19 testing at the in-person meeting comes on top of the event’s already robust safety protocols that require all meeting participants to be vaccinated, and all meeting participants to have received a negative PCR or antigen COVID-19 test within 72 hours of arriving at the convention center.

To make the testing requirement as convenient as possible, AACC in association with LumiraDX will provide an onsite mobile testing unit outside the convention centre main doors where all in-person attendees can obtain a free COVID-19 test on a first come, first served basis. The results will take 30 minutes from sample collection. Attendees can avoid the necessity of fitting testing into their conference schedule by securing a test before leaving for Atlanta, as long as it falls within the three-day window. Additionally, the AACC will provide the attendees with COVID-19 self-test packets while they are at the conference and also as they prepare to return home, although supplies will be limited to the first 3,000 requests.

Related Links:
American Association for Clinical Chemistry
LumiraDx


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article
AACC

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.